Is ACMB or JNJ a better dividend investment in 2026?

ACMB currently yields 5714.29% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: ACMB offers higher current income.

What is the dividend yield difference between ACMB and JNJ?

ACMB has a forward dividend yield of 5714.29% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 5712.15 percentage points.

Home › Compare › ACMB vs JNJ

ACMB vs JNJ: Dividend Comparison 2026

ACMB yields 5714.29% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ACMB wins by $228153224412509.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ACMB

● Live price

5714.29%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$228153224412509.59M

Annual income

$220,560,399,839,122,060,000.00

Full ACMB calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — ACMB vs JNJ

📍 ACMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ACMB	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ACMB + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ACMB pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACMB

Annual income on $10K today (after 15% tax)

$485,714.29/yr

After 10yr DRIP, annual income (after tax)

$187,476,339,863,253,750,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, ACMB beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACMB + JNJ for your $10,000?

ACMB: 50%JNJ: 50%

100% JNJ50/50100% ACMB

Portfolio after 10yr

$114076612206254.81M

Annual income

$110,280,199,919,561,030,000.00/yr

Blended yield

96.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACMB

No analyst data

Altman Z

0.0

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACMB buys

JNJ buys

No recent congressional trades found for ACMB or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricACMBJNJ

Forward yield	5714.29% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$228153224412509.59M ✓	$30.5K
Annual income after 10y	$220,560,399,839,122,060,000.00 ✓	$4,749.88
Total dividends collected	$227641622319776.13M ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ACMB vs JNJ ($10,000, DRIP)

Year	ACMB Portfolio	ACMB Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$582,129	$571,428.57	$10,594	$274.49	+$571.5K → ACMB
2	$31,711,186	$31,088,308.22	$11,294	$360.69	+$31.70M → ACMB
3	$1,616,661,128	$1,582,730,159.44	$12,133	$476.91	+$1616.65M → ACMB
4	$77,139,944,357	$75,410,116,950.20	$13,156	$635.42	+$77139.93M → ACMB
5	$3,445,379,409,484	$3,362,839,669,021.90	$14,432	$854.61	+$3445379.40M → ACMB
6	$144,058,436,084,716	$140,371,880,116,567.28	$16,056	$1,162.76	+$144058436.07M → ACMB
7	$5,639,412,164,337,400	$5,485,269,637,726,755.00	$18,175	$1,604.53	+$5639412164.32M → ACMB
8	$206,716,597,857,094,600	$200,682,426,841,253,570.00	$21,009	$2,252.68	+$206716597857.07M → ACMB
9	$7,096,097,732,137,874,000	$6,874,910,972,430,782,000.00	$24,911	$3,229.73	+$7096097732137.85M → ACMB
10	$228,153,224,412,509,600,000	$220,560,399,839,122,060,000.00	$30,458	$4,749.88	+$228153224412509.56M → ACMB

ACMB vs JNJ: Complete Analysis 2026

ACMB — Stock

Agro Capital Management Corp. does not have significant operations. Previously, the company was engaged in online tourist guide business. It intends to enter into a merger, acquisition, or other business venture transaction with companies operating in the aqua-culture development industry in Malaysia. The company was formerly known as Guate Tourism Inc. and changed its name to Agro Capital Management Corp. in December 2015. Agro Capital Management Corp. was founded in 2013 and is based in New York, New York.

Full ACMB Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ACMB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACMB vs SCHD ACMB vs JEPI ACMB vs O ACMB vs KO ACMB vs MAIN ACMB vs ABBV ACMB vs MRK ACMB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.